Journal of Internal Medicine Concepts & Practice ›› 2021, Vol. 16 ›› Issue (01): 37-44.doi: 10.16138/j.1673-6087.2021.01.009
• Original article • Previous Articles Next Articles
CHEN Chen, YIN Shanshan, GUO Jiahui, GAO Fenghou()
Received:
2020-09-16
Online:
2021-02-25
Published:
2022-07-26
Contact:
GAO Fenghou
E-mail:fenghougao@163.com
CLC Number:
CHEN Chen, YIN Shanshan, GUO Jiahui, GAO Fenghou. Degradation of PTEN mRNA by microRNA-29 family promotes survival and lymph node invasion of non-small cell lung cancer cell[J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(01): 37-44.
[1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
doi: 10.3322/caac.21492 URL |
[2] | Osmani L, Askin F, Gabrielson E, et al. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): moving from targeted therapy to immunotherapy[J]. Semin Cancer Biol, 2018, 52 Pt 1: 103-109. |
[3] |
Dai C, Ren Y, Xie D, et al. Does lymph node metastasis have a negative prognostic impact in patients with NSCLC and M1a disease[J]?. J Thorac Oncol, 2016, 11(10): 1745-1754.
doi: 10.1016/j.jtho.2016.06.030 URL |
[4] |
Worby CA, Dixon JE. PTEN[J]. Annu Rev Biochem, 2014, 83: 641-669.
doi: 10.1146/annurev-biochem-082411-113907 URL |
[5] |
Tang JM, He QY, Guo RX, et al. Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis[J]. Lung Cancer, 2006, 51(2): 181-191.
doi: 10.1016/j.lungcan.2005.10.003 URL |
[6] | Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay[J]. Nat Rev Genet, 2010, 11(9): 597-610. |
[7] |
Liu H, Cheng L, Cao D, et al. Suppression of miR-21 expression inhibits cell proliferation and migration of liver cancer cells by targeting phosphatase and tensin homolog (PTEN)[J]. Med Sci Monit, 2018, 24: 3571-3577.
doi: 10.12659/MSM.907038 URL |
[8] | Lou Y, Yang X, Wang F, et al. MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein[J]. Int J Mol Med, 2010, 26(6): 819-827. |
[9] |
Feng X, Jiang J, Shi S, et al. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway[J]. Int J Oncol, 2016, 49(6): 2600-2610.
doi: 10.3892/ijo.2016.3751 URL |
[10] |
Jing ZF, Bi JB, Li ZL, et al. miR-19 promotes the proliferation of clear cell renal cell carcinoma by targeting the FRK-PTEN axis[J]. Onco Targets Ther, 2019, 12: 2713-2727.
doi: 10.2147/OTT.S199238 URL |
[11] |
Kwon JJ, Factora TD, Dey S, et al. A systematic review of miR-29 in cancer[J]. Mol Ther Oncolytics, 2019, 12: 173-1794.
doi: 10.1016/j.omto.2018.12.011 URL |
[12] |
Robert J. Biology of cancer metastasis[J]. Bull Cancer, 2013, 100(4): 333-342.
doi: 10.1684/bdc.2013.1724 URL |
[13] |
Deng H, Wu RL, Zhou HY, et al. Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer[J]. World J Gastroenterol, 2006, 12(7): 1013-1017.
doi: 10.3748/wjg.v12.i7.1013 URL |
[14] |
Wu Y, Song Y, Xiong Y, et al. MicroRNA-21 (Mir-21) promotes cell growth and invasion by repressing tumor suppressor PTEN in colorectal cancer[J]. Cell Physiol Biochem, 2017, 43(3): 945-958.
doi: 10.1159/000481648 URL |
[15] |
Feng C, Yao R, Huang F, et al. High level of PTEN expression is associated with low-grade liver metastasis and satisfactory patient survival in pancreatic cancer[J]. Arch Med Res, 2011, 42(7): 584-588.
doi: 10.1016/j.arcmed.2011.10.008 URL |
[16] |
Gkountakos A, Sartori G, Falcone I, et al. PTEN in lung cancer: dealing with the problem, building on new knowledge and turning the game around[J]. Cancers (Basel), 2019, 11(8): 1141.
doi: 10.3390/cancers11081141 URL |
[17] | Molinari F, Frattini M. Functions and regulation of the PTEN gene in colorectal cancer[J]. Front Oncol, 2013, 3: 326. |
[18] |
Kim DH, Suh J, Surh YJ, et al. Regulation of the tumor suppressor PTEN by natural anticancer compounds[J]. Ann N Y Acad Sci, 2017, 1401(1): 136-149.
doi: 10.1111/nyas.13422 URL |
[19] |
Lu J, Jeong HW, Kong N, et al. Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex[J]. PLoS One, 2009, 4(5): e5577.
doi: 10.1371/journal.pone.0005577 URL |
[20] |
Di Giorgio E, Clocchiatti A, Piccinin S, et al. MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation[J]. Mol Cell Biol, 2013, 33(22): 4473-4491.
doi: 10.1128/MCB.01050-13 pmid: 24043307 |
[21] |
Poliseno L, Pandolfi PP. PTEN ceRNA networks in human cancer[J]. Methods, 2015, 77-78: 41-50.
doi: 10.1016/j.ymeth.2015.01.013 pmid: 25644446 |
[22] |
Jang SJ, Choi IS, Park G, et al. MicroRNA-205-5p is upregulated in myelodysplastic syndromes and induces cell proliferation via PTEN suppression[J]. Leuk Res, 2016, 47: 172-177.
doi: 10.1016/j.leukres.2016.06.003 URL |
[23] |
Yang Y, Guo JX, Shao ZQ. miR-21 targets and inhibits tumor suppressor gene PTEN to promote prostate cancer cell proliferation and invasion: an experimental study[J]. Asian Pac J Trop Med, 2017, 10(1): 87-91.
doi: S1995-7645(16)30448-5 pmid: 28107872 |
[24] |
Alizadeh M, Safarzadeh A, Beyranvand F, et al. The potential role of miR-29 in health and cancer diagnosis, prognosis, and therapy[J]. J Cell Physiol, 2019, 234(11): 19280-19297.
doi: 10.1002/jcp.28607 pmid: 30950056 |
[25] |
Ślusarz A, Pulakat L. The two faces of miR-29[J]. J Cardiovasc Med (Hagerstown), 2015, 16(7): 480-490.
doi: 10.2459/JCM.0000000000000246 URL |
[1] | YAN Bo (颜波), FU Shijie (傅世杰), CHANG Yuanyuan (常媛媛), GU Aiqin (顾爱琴), DONG Qianggang (董强刚), LI Rong (李榕) . Mutational Analysis of OCT4+ and OCT4- Circulating Tumour Cells by Single Cell Whole Exome Sequencing in Stage I Non-Small Cell Lung Cancer Patients [J]. J Shanghai Jiaotong Univ Sci, 2021, 26(1): 40-46. |
[2] | WANG Jiahui, LI Ning, SUN Xianwen, LIN Yingni, DING Yongjie, SONG Hejie, LI Qingyun. The magnitude and clinical implication of SERPINA1 and FHIT methylation in non-small cell lung cancer based on analysis of TCGA database [J]. Journal of Internal Medicine Concepts & Practice, 2021, 16(02): 103-107. |
[3] | DU Hailei, CHEN Ling, LUO Fangxiu, LI Yong, CHENG Qijian, ZHU Lianggang, HANG Junbiao. The prognostic value of Beclin-1 and Bcl-2 and its relationship with pathological characteristics in patients with non-small cell lung cancer [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 258-263. |
[4] | GU Shengjia, CAO Qiqi, YAN Fuhua, YANG Wenjie. Quantitative assessment of therapy response of non-small cell lung cancer with dual-energy CT [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(05): 526-532. |
[5] | . [J]. Journal of Diagnostics Concepts & Practice, 2013, 12(04): 462-465. |
[6] | . [J]. Journal of Diagnostics Concepts & Practice, 2012, 11(02): 167-171. |
[7] | . [J]. Journal of Internal Medicine Concepts & Practice, 2012, 7(02): 110-113. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||